Apolipoprotein E (ApoE), a Bmp-2 (bone morphogenetic protein) upregulated gene in mesenchymal progenitors (C3H10T1/2), is highly expressed in murine embryonic development

BioFactors

Volumn 9, Issue 1, 1999, Pages 11-17

  Bächner, Dietmar ^a   Schröder, Dietmar ^a   Betat, Nicole ^a   Ahrens, Marion ^a   Gross, Gerhard ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

ApoE; Bmp; C3H10T1 2; In Situ hybridization; Mesenchymal differentiation; Neural crest; Subtractive cloning

Indexed keywords

APOLIPOPROTEIN E; BONE MORPHOGENETIC PROTEIN 2;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MESENCHYME; MOUSE; NEURAL CREST; NONHUMAN; ORGANOGENESIS; OSTEOBLAST; PRIORITY JOURNAL; STEM CELL; TISSUE DIFFERENTIATION;

EID: 2442762441     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520090103     Document Type: Article

References (24)

1. C.A. Reznikoff, D.W. Brankow and C. Heidelberger, Establishment and characterization of a cloned cell line of C3H mouse embryo cells sensitive to postconfluence inhibition of division, Cancer Res. 33 (1973), 3231-3238.
2. S.M. Taylor and P.A. Jones, Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine, Cell 17 (1979), 771-779.
3. E.A. Wang, D.I. Israel, S. Kelly and D.P. Luxenberg, Bone morphogenetic protein causes commitment and differentiation in C3H10T1/2 and 3T3 cells, Growth Factors 9 (1993), 57-71.
4. M. Ahrens, T. Ankenbauer, D. Schröder, A. Hollnagel, H. Mayer and G. Gross, Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages, DNA Cell Biol. 12 (1993), 871-880.
5. D. Gazit, R. Ebner, A.J. Kahn and R. Derynck, Modulation of expression and cell surface binding of members of the transforming growth factor-β superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells, Mol. Endocrinol. 7 (1993), 189-198.
6. D. Scheddin, H. Mayer, S. Wittmann, B. Schönecker, S. Gliesing and M. Reichenbacher, Synthesis and biological activities of 26-hydroxy-27-nor-derivatives of 1-alpha, 25-dihydroxyvitamin D3, Steroids 61 (1996), 598-608.
7. M.A. Paulik and J.M. Lenhard, Thiazolidinediones inhibit alkaline phosphatase activity while increasing expression of uncoupling protein, deiodinase, and increasing mitochondrial mass in C3H10T1/2 cells, Cell Tissue Res. 290 (1997), 79-87.
8. E. Chalaux, T. López-Rovira, J.L. Rosa, R. Bartrons and F. Ventura, JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2, J. Biol. Chem. 273 (1998), 537-543.
9. A.H. Reddi, Regulation of cartilage and bone differentiation by bone morphogenetic proteins, Curr. Opin. Cell Biol. 4 (1992), 850-855.
10. J.M. Wozney, Bone morphogenetic proteins, Prog. Growth Factor Res. 1 (1989), 267-280.
11. 1, mRNA expression, Proc. Natl. Acad. Sci. USA 89 (1992), 11 740-11 744.
12. V.M. Paralkar, B.S. Weeks, Y.M. Yu, H.K. Kleinman and A.H. Reddi, Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen, J. Cell Biol. 119 (1992), 1721-1728.
13. G. Perides, R.M. Safran, L.A. Downing and M.E. Charness, Regulation of neural cell adhesion molecule and L1 by the transforming growth factor-β superfamily. Selective effects of the bone morphogenetic proteins, J. Biol. Chem. 269 (1994), 765-770.
14. B.L.M. Hogan, Bone morphogenetic proteins: multifunctional regulators of vertebrate development, Genes Dev. 10 (1996), 1580-1594.
15. D. Bächner, M. Ahrens, D. Schröder, A. Hoffmann, J. Lauber, N. Betat, P. Steinert, L. Flohé and G. Gross, Dev. Dyn. (1998) (in press).
16. A.D. Roses, Apolipoprotein E, a gene with complex biological interactions in the aging brain, Neurobiol. Dis. 4 (1997), 170-185.
17. T.A. Owen, M. Aronow, V. Shalhoub, L.M. Barone, L. Wilming, M.S. Tassinari, M.B. Kennedy, S. Pockwinse, J.B. Lian and G.S. Stein, Progressive development of the rat osteoblast phenotype in vitro, reciprocal relationships in the expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix, J. Cell. Physiol. 143 (1990), 420-430.
18. B. Rosen and R.S.P. Beddington, Whole mount in situ hybridization in the mouse embryo: gene expression in three dimensions, Trends. Genet. 9 (1993), 162-167.
19. D. Bächner,; A. Manca, P. Steinbach, D. Wöhrle, W. Just, W. Vogel, H. Hameister and A. Poustka, Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and female gonad, Hum. Mol. Genet. 2 (1993), 2043-2050.
20. J. Sambrook, E.F. Fritsch and R. Maniatis, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
21. A.S. Plump, J.D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J.G. Verstuyft, E.M. Rubin and J.L. Breslow, Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells, Cell 71 (1992), 343-353.
22. M.H. Hofker, B.J. van Vlijmen and L.M. Havekes, Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis, Atherosclerosis 137 (1998), 1-11.
23. T. Vogel, N.H. Guo, R. Guy, N. Drezlich, H.C. Krutzsch, D.A. Blake, A. Panet and D.D. Roberts, Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation, J. Cell Biochem. 54 (1994), 299-308.
24. P.J. Babin, C. Thisse, M. Durliat, M. Andre, M.A. Akimenko and B. Thisse, Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development, Proc. Natl. Acad. Sci. USA 94 (1997), 8622-8627.